-+ 0.00%
-+ 0.00%
-+ 0.00%

D. Boral Capital Maintains Buy on CollPlant Biotechnologies, Maintains $14 Price Target

Benzinga·02/12/2025 15:07:41
Listen to the news
D. Boral Capital analyst Jason Kolbert maintains CollPlant Biotechnologies (NASDAQ:CLGN) with a Buy and maintains $14 price target.